9 P- l y; b P' nDevelopment of Novel Vaccines' Z" A0 u" c$ h+ q% z: l, o
* F# O7 V! o; P: O! NSkills, Knowledge and Translational Technologies / w9 L; j8 @& m2 t0 R1 x/ M& l/ |: ?5 R5 |7 ?3 _
Editors: von Gabain, Alexander, Klade, Christoph (Eds.) " R: }# I. C/ S w9 C( h8 r l! Q6 f- A, ?" a
) M) |2 U* R U$ E X
[attach]2207[/attach]" T$ i* X5 [) j6 o' C About this book6 S @( u6 x" K4 L1 w8 Q# O
& S/ n. ]# M/ j
“Development of novel vaccines” gives an overview of the tasks in basic research leading to the final product – the vaccine and its applications, belonging to the most complex biologics in the pharmaceutical field. Distinct from most textbooks in the vaccine arena, the current issue focuses on the translational aspect, namely, how research results can be transformed into life-saving medical interventions. Each chapter of the book deals with one important paradigm for the development of novel vaccines, along the value chain towards the final vaccine, and furthermore, with the inevitable tools required for this process. Contributions are prepared by teams of scientists, all of whom are experts in the field, most of them anchored in biomedical organizations devoted to translational culture, thereby lighting the certain topics from different views. This volume is a must read for researchers engaged in vaccine development and who really want to see their research results to become a product. 3 ~! F' P; t" O6 k * ~2 r% L! I5 j) Q; r3 y: T 9 ^- o g4 u( aTable of contents (11 chapters), M* `( k; v5 J
! E9 t( w U. m7 n( L 8 @+ [5 F: S9 A; [) z! rSkills, Knowledge, and Translational Technologies Leading to Novel Vaccines & C& w. Q) @0 r, t0 k * j" J1 k5 b8 Q2 ^! D6 L: F9 G. S/ C( nAlkan, Şefik Ş. % z* a6 i( J' v( ? . {5 y7 K& t- Z9 JPages 1-26 0 h" ^" @2 j s) k; x6 {+ H, v% s8 O
Finding Protective Bacterial Antigens2 C" p1 B' G8 s& a7 x) O) @2 j
* g8 ?5 O7 ^6 ^# |+ ~: E
Grandi, Guido (et al.)# C. o$ [- |# G; w2 L
! b- U# A6 R- q" qPages 27-44 / t9 L' |/ O0 N1 l' @" t! Q: z7 O X% @/ I9 O, ~
& x$ q/ Y, s6 U; V- a0 l4 p4 EEnhancing and Tailoring the Immunogenicity of Vaccines with Novel Adjuvants& i* |1 |& v4 B- E
% i* a1 B0 L! Z6 v( P
Fox, Christopher B. (et al.)8 `$ o8 _1 q6 k* D/ h2 b
' I- b/ b0 w) k+ wPages 45-72 4 j7 A. o8 `. E, K6 e0 N+ n% w ^4 |. s; N* L# P% D+ r
% @; A2 L/ p2 `! v
+ {9 h/ I ~" g/ [: v$ j0 N( N
Vaccine Delivery: Beyond Needles " C+ W8 f7 O% d4 @# H" k" O i 4 Q1 A! `0 c1 R; iFlyer, David C. (et al.): O2 a3 X( A& n+ Z" v
" V" f _, Y& r; L
Pages 73-869 a3 s& b( Z7 c( n
, J5 D! S* H6 J, c: T0 q/ J) J" ^# o* x% ~0 Q
6 P( k( {7 F8 t/ V
Employing Live Microbes for Vaccine Delivery ) |2 b+ T' L a4 ` 5 f; w" ?7 u3 G* VLoessner, Holger (et al.)# m( S' r1 d8 b% c& q; Q& O. x' Q
. T9 z; u0 m0 ?+ R. g1 d
Pages 87-124 - ?3 j- `1 i+ Q, ` ~5 R" k+ l- M8 ~+ \
; i2 ]5 d$ ]9 H7 J w1 j " K% }& \/ H0 |. g8 R) _Synthesizing Vaccines with Microbes T3 V1 z' d3 c+ u9 s1 A5 o
0 N! T5 K' K- \( F1 ` e; BWacker, Michael (et al.)5 p, d& h, a# a% s) ^/ Y
1 n5 K. a: L9 r; |4 I4 c
Pages 125-1447 h% g; } z3 \: v+ }+ ^) ?9 x: ~. P
$ Y y+ B/ t8 P( ^
2 D+ ^; z! J2 P2 ~& w
& D T& I1 d/ T4 GPurification and Formulation: Silent but Important Players in Vaccine Development1 y+ H- z5 v; h+ N+ E6 Y' m' t
' x: X7 I! A3 V/ ZSchlegl, Robert (et al.) 4 p& ^+ W' [; I$ O+ E 9 {5 h, U3 q/ R& gPages 145-188 - q6 v# ?. o3 B- n4 n& D# ?& x' A* [) B2 A' q$ B' P' Z% s1 x9 D
2 u7 _9 ?) }4 N$ e) g 6 F( x" P$ D$ o H$ pCutting-Edge Approaches Toward Novel and Cross-Protective Influenza Vaccines : O: x! Q; V* q T& j' q( d. Z; j" D) f- b7 K. {& m: c/ B4 t
Arnon, Ruth (et al.) 2 K5 o* @; Z1 A7 m: {6 n; q# I7 i7 a) ^/ U' h( F9 f6 n0 x2 @$ _0 ], a
Pages 189-204 ; \8 |4 W/ r! C: E9 J$ k! S, l+ R+ M+ P+ G3 [* G! S* j$ v
1 Z2 U2 d: Y& o - P: H; i/ ]& t, y( o& RCutting Edge Approaches Toward Novel and Cross-Protective Influenza Vaccines , D$ {; C! b4 c" ]" G! h3 Z, N1 j* Z
Roose, Kenny (et al.) ; O; E& U0 b1 z. `. w! d6 Y# c2 B
Pages 205-2329 g4 G. r/ _& ]% n# I2 @
% d1 G/ E6 ?3 I- D7 d7 P& Z$ Q/ W1 Q3 V$ b! o1 m
; ^0 E; i* z, @9 _' KExamples of Novel Registered Prophylactic Vaccines, HPV, and JEV 9 y2 }5 w3 G8 h2 A8 J7 z" d5 y* t0 x8 ^, h! X' J) A6 c& O) L
Dubischar-Kastner, Katrin (et al.) * F2 l3 w, j) g8 R: [, O! [7 {2 n V. a- K1 V
Pages 233-286 5 a9 u; ^1 Z, ]+ {, W. G' j4 j' G' _( g8 M% U+ a. A
9 H7 }- `7 }$ N
# S, {; |2 W. r! I# T9 \
The Bumpy Road Toward Vaccine Registration: How to Overcome Regulatory Hurdles H: r8 M1 _1 [; F. F) M/ s' ]' C- H3 [$ e: I. u8 ]% a$ g
Pfleiderer, Michael' H& G* w, y8 z8 [' n: n& I, ?
. B8 \0 {$ ^2 w3 R: @7 i5 V
Pages 287-3008 k/ s9 P2 `& v8 e/ L$ P
) s4 e" a; J" |7 \* v. E
下载链接： 1 f# {$ |# h/ C0 ]& _8 E; c. }% R4 l " w* D1 J" w5 b' E" R作者: Biodog 时间: 2016-8-27 12:54
感谢分享 ) a- K/ H g. k6 \& X作者: hydwangyong 时间: 2016-8-29 07:53
谢谢分享作者: borntotry1 时间: 2016-9-23 09:25
正是需要的作者: borntotry1 时间: 2016-9-23 09:26
正是我需要的，谢谢分享作者: chenzongxiang 时间: 2016-10-9 10:33
谢谢分享，好好学习！作者: 序道 时间: 2016-10-9 10:54
学习学习下作者: freud1981213 时间: 2016-11-16 22:38
a good book作者: freud1981213 时间: 2016-11-16 22:39
无法下载？？作者: 序道 时间: 2016-11-21 21:25
不错3 T( q F+ }8 i3 P) [. K" n 作者: zhpu2008 时间: 2017-6-10 16:34
谢谢分享作者: 迷你大笨象 时间: 2017-8-5 10:48
感谢分享 自己也要给大家分享自己手上的电子书作者: 樽满秋华 时间: 2017-8-15 15:30
支持~作者: liqis1992@163.c 时间: 2017-8-17 15:01
哈哈哈哈哈哈作者: tangran0323 时间: 2017-8-19 19:07
感谢分享# l' e1 n& \2 m' {- G! D 作者: hnzwb 时间: 2017-12-25 21:22
不错的资料，看看作者: ASun 时间: 2018-1-2 15:06
感谢楼主分享！作者: tangseng918 时间: 2018-4-16 14:25
谢谢楼主的分享！！！作者: Melissa晨曦 时间: 2018-5-2 11:25
谢谢分享作者: lincoln2013v 时间: 2020-8-19 16:25
谢谢分享. g! I% p8 G2 k6 U- M0 s! w. _4 N* n( D 作者: Aprilcancer 时间: 2020-9-18 11:33
谢谢楼主的分享